Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria
Alnylam Pharmaceuticals
Manisha Balwani; Eliane Sardh; Paolo Ventura; Paula Aguilera Peiró; David C Rees; Ulrich Stölzel; D Montgomery Bissell; Herbert L Bonkovsky; Jerzy Windyga; Karl E Anderson; Charles Parker; Samuel M Silver; Siobán B Keel; Jiaan-Der Wang; Penelope E Stein; Pauline Harper; Daphne Vassiliou; Bruce Wang; John Phillips; Aneta Ivanova; Janneke G Langendonk; Raili Kauppinen; Elisabeth Minder; Yutaka Horie; Craig Penz; Jihong Chen; Shangbin Liu; John J Ko; Marianne T Sweetser; Pushkal Garg; Akshay Vaishnaw; Jae B Kim; Amy R Simon; Laurent Gouya; ENVISION Investigators